OBJECTIVE: Thoracic aortic aneurysms (TAAs) develop by a multifactorial process involving maladaptive signaling pathways that alter the aortic vascular environment. Transforming growth factor-beta (TGF-beta) has been implicated in regulating the structure and composition of the extracellular matrix by differential activation of various intracellular signaling pathways. However, whether and to what degree TGF-beta signaling contributes to TAA development remains unclear. Accordingly, the hypothesis that alterations in TGF-beta signaling occur during aneurysm formation was tested in a murine model of TAA. METHODS: TAAs were surgically induced in mice (C57BL/6J) and aortas were analyzed at predetermined time points (1, 2, and 4 weeks post-TAA induction). Quantitative real-time PCR (QPCR) was performed to evaluate the expression of 84 relevant TGF-beta superfamily genes, and the protein levels of key signaling intermediates were measured by immunoblotting. Results were compared to unoperated reference control mice. RESULTS: QPCR revealed increased expression of TGF-beta superfamily ligands (Gdf-2, -6, -7, Inhba), ligand inhibitors (Bmper, Chrd, Gsc), and transcriptional regulators (Dlx2, Evi1), among other genes (Cdkn2b, Igf1, IL-6). Protein levels of TGF-beta receptor(II), Smad2, Smad1/5/8, phospho-Smad1/5/8, and Smurf1 were increased from control values post-TAA induction. Both TGF-beta receptor(I) and Smad4 were decreased from control values, while ALK-1 levels remained unchanged. CONCLUSIONS: These alterations in the TGF-beta pathway suggest a mechanism by which primary signaling is switched from a TGF-betaR(I)/Smad2-dependent response, to an ALK-1/Smad1/5/8 response, representing a significant change in signaling outcome, which may enhance matrix degradation. Copyright 2008 S. Karger AG, Basel.
OBJECTIVE: Thoracic aortic aneurysms (TAAs) develop by a multifactorial process involving maladaptive signaling pathways that alter the aortic vascular environment. Transforming growth factor-beta (TGF-beta) has been implicated in regulating the structure and composition of the extracellular matrix by differential activation of various intracellular signaling pathways. However, whether and to what degree TGF-beta signaling contributes to TAA development remains unclear. Accordingly, the hypothesis that alterations in TGF-beta signaling occur during aneurysm formation was tested in a murine model of TAA. METHODS: TAAs were surgically induced in mice (C57BL/6J) and aortas were analyzed at predetermined time points (1, 2, and 4 weeks post-TAA induction). Quantitative real-time PCR (QPCR) was performed to evaluate the expression of 84 relevant TGF-beta superfamily genes, and the protein levels of key signaling intermediates were measured by immunoblotting. Results were compared to unoperated reference control mice. RESULTS: QPCR revealed increased expression of TGF-beta superfamily ligands (Gdf-2, -6, -7, Inhba), ligand inhibitors (Bmper, Chrd, Gsc), and transcriptional regulators (Dlx2, Evi1), among other genes (Cdkn2b, Igf1, IL-6). Protein levels of TGF-beta receptor(II), Smad2, Smad1/5/8, phospho-Smad1/5/8, and Smurf1 were increased from control values post-TAA induction. Both TGF-beta receptor(I) and Smad4 were decreased from control values, while ALK-1 levels remained unchanged. CONCLUSIONS: These alterations in the TGF-beta pathway suggest a mechanism by which primary signaling is switched from a TGF-betaR(I)/Smad2-dependent response, to an ALK-1/Smad1/5/8 response, representing a significant change in signaling outcome, which may enhance matrix degradation. Copyright 2008 S. Karger AG, Basel.
Authors: N M Wolfman; G Hattersley; K Cox; A J Celeste; R Nelson; N Yamaji; J L Dube; E DiBlasio-Smith; J Nove; J J Song; J M Wozney; V Rosen Journal: J Clin Invest Date: 1997-07-15 Impact factor: 14.808
Authors: M Kurokawa; K Mitani; K Irie; T Matsuyama; T Takahashi; S Chiba; Y Yazaki; K Matsumoto; H Hirai Journal: Nature Date: 1998-07-02 Impact factor: 49.962
Authors: John S Ikonomidis; Elizabeth K Nadeau; Adam W Akerman; Robert E Stroud; Rupak Mukherjee; Jeffrey A Jones Journal: J Thorac Cardiovasc Surg Date: 2016-11-14 Impact factor: 5.209
Authors: Jeffrey A Jones; Juozas A Zavadzkas; Eileen I Chang; Nina Sheats; Christine Koval; Robert E Stroud; Francis G Spinale; John S Ikonomidis Journal: J Thorac Cardiovasc Surg Date: 2010-03-09 Impact factor: 5.209
Authors: Rupak Mukherjee; William T Rivers; Jean Marie Ruddy; Robert G Matthews; Christine N Koval; Rebecca A Plyler; Eileen I Chang; Risha K Patel; Christine B Kern; Robert E Stroud; Francis G Spinale Journal: Circulation Date: 2010-06-21 Impact factor: 29.690
Authors: Jeffrey A Jones; Christy Beck; John R Barbour; Jouzas A Zavadzkas; Rupak Mukherjee; Francis G Spinale; John S Ikonomidis Journal: Am J Pathol Date: 2009-09-03 Impact factor: 4.307
Authors: Lee B Smith; Patrick W F Hadoke; Emma Dyer; Martin A Denvir; David Brownstein; Eileen Miller; Nancy Nelson; Sara Wells; Michael Cheeseman; Andy Greenfield Journal: Cardiovasc Res Date: 2010-11-10 Impact factor: 10.787